Physician urges greater recognition of how ‘misfearing’ influences women’s perceptions of heart health risks — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/02/140213141958.htm
source : http://www.sciencedaily.com/releases/2014/02/140213141958.htm
source : http://www.sciencedaily.com/releases/2014/02/140207083927.htm
A new finding by University of Pennsylvania scientists has identified key steps that trigger this disintegration of cellular regulation. Their discovery — that a protein called Exo70 has a split personality, with one form keeping cells under tight control and another contributing to the ability of tumors to invade distant parts of the body — points to new possibilities for diagnosing cancer metastasis. The research, published in the journal Developmental Cell, was conducted by a team of researchers from the School of Arts and Sciences’ Department of Biology; the Perelman School of Medicine’s pathobiology and laboratory medicine, medicine and genetics departments, and China’s Hangzhou Normal University School of Medicine. …
In the largest study of its kind, researchers led by the University of Pennsylvania School of Nursing have investigated the caregivers of 186 mothers to childhood brain tumor survivors aged 14-40 whose care needs last long into adulthood. They based their research on a model containing factors central to nursing practice, namely the caregiver, the survivor, and the family. They discovered that a complex interaction among components of the model, the health of the caregivers, the demands experienced by the caregiver, the caregiver’s perceptions about the health of the survivor, and the family’s support interact to explain how the caregiver assesses herself in her role. …
With graduate student Maria Elena De Obaldia, Bhandoola describes in Nature Immunology this month how Notch signaling induces expression of genes that promote the maturation of T cells and discourage alternative cell fates. …
Results from a willingness to participate study, led by Charles B. …
The preclinical and clinical results, which have set the stage for a first-of-its-kind prospective study, point to metformin as an effective radiosensitizer — adrug that makes tumor cells more sensitive to radiation therapy — to treat stage III non-small cell lung cancer (NSCLC). Because of poor local response and five-year survival rates around 15 percent in late-stage NSCLC patients, well-tolerated, combination therapies are greatly needed. The abstract is being presented by Ildiko Csiki, MD, PhD, an assistant professor of Radiation Oncology at Penn’s Abramson Cancer Center. Metformin, the most-widely used drug for type-2 diabetes, has been shown to have anti-cancer effects on a number of cancers, including prostate and colon…
"Dogs are part of the family and we do everything we can to relieve them of pain and discomfort when they are sick," said Dorothy Cimino Brown, D.V.M., School of Veterinary Medicine, University of Pennsylvania, Philadelphia. "In addition to sharing emotional attachments with our dogs, humans share many of the same ailments our pets suffer when fighting cancer. By studying the positive pain relief this treatment afforded dogs, we are hopeful it may also be effective for humans." The evolution of bone cancer pain in dogs parallels what occurs in humans, with the frequency and intensity of pain increasing over weeks and months. As the cancer advances, both canine and human patients experience life-altering pain, which greatly affects their daily activities and quality of life. …
"Increased use of single fraction treatment would achieve the Holy Grail of health reform, which is real improvements in patient care at substantial cost savings," said the new study’s lead author, Justin E. Bekelman, MD, an assistant professor of Radiation Oncology in Penn Medicine’s Abramson Cancer Center…
About 25 million people live in the 13 states that make up the Appalachian region, a 205,000-square-mile region that follows the spine of the Appalachian Mountains from southern New York to northern Mississippi. The National Cancer Institute has recently publicized Appalachia’s higher rates of cancer and poorer outcomes for residents diagnosed with cancer. To examine regional disparities in breast cancer screening and diagnosis, researchers evaluated Central Cancer Registry and Medicare claims data from three Appalachian states (Kentucky, Ohio, and Pennsylvania) to measure the incidence of later stage breast cancer in the region’s poorest counties compared with its more affluent counties. …